Veracyte | VCYT - Ebit

Stock Price
38.48
Daily Change
-0.42 -1.08%
Monthly
16.50%
Yearly
31.78%
Q2 Forecast
37.71

Veracyte reported $19.08M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Agenus USD 14.4M 19.26M Dec/2025
Agilent USD 353M 90M Dec/2025
Anika Therapeutics USD 646K 3.88M Dec/2025
Arrowhead Research USD -141.26M 182.07M Mar/2026
Bruker USD 10.2M 66.1M Mar/2026
Heron Therapeutics USD 38K 3.83M Dec/2025
Illumina USD 239M 17M Mar/2026
Intrexon USD -26.3M 2.91M Jun/2024
Karyopharm Therapeutics USD -17.84M 8.44M Dec/2025
Laboratory Of America USD 410.1M 28.1M Mar/2026
Ligand Pharmaceuticals USD 60.33M 1.76M Mar/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Roche Holding CHF 9.56B 2.1B Dec/2025
Siemens EUR 2.68B 113M Mar/2026
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Veracyte USD 19.08M 5.55M Mar/2026
Waters USD 148M 122.52M Mar/2026